Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Review
. 2023 Jan 15;24(2):1732.
doi: 10.3390/ijms24021732.

Integrative Hematology: State of the Art

Affiliations
Review

Integrative Hematology: State of the Art

Francesca Andreazzoli et al. Int J Mol Sci. .

Abstract

Blood cancers are a group of diseases with thus far frequently poor prognosis. Although many new drugs, including target therapies, have been developed in recent years, there is still a need to expand our therapeutic armamentarium to better deal with these diseases. Integrative hematology was conceived as a discipline that enriches the patient's therapeutic possibilities with the use of supplements, vitamins and a nutritional approach aiming at improving the response to therapies and the clinical outcome. We will analyze the substances that have proved most useful in preclinical and clinical studies in some of the most frequent blood diseases or in those where these studies are more numerous; the importance of the nutritional approach and the role of the intestinal microbiota will also be emphasized.

Keywords: gut microbiota; hematological cancer; integrative medicine; leukemia; multiple myeloma; myelodysplastic syndromes; vitamin D.

PubMed Disclaimer

Conflict of interest statement

The authors declare no conflict of interest.

Figures

Figure 1
Figure 1
Integrative hematology: a multisystemic approach.

References

    1. Bonucci M., Andreazzoli F. New approach of Integration: Integrative Hematology. Br. J. Res. 2017;4:6.
    1. Deng G., Cassileth B. Integrative Oncology: An Overview. Am. Soc. Clin. Oncol. Educ. Book. 2014;34:233–242. doi: 10.14694/EdBook_AM.2014.34.233. - DOI - PubMed
    1. Tefferi A., Barbui T. Polycythemia Vera and Essential Thrombocythemia: 2017 update on diagnosis, risk-stratification, and management. Am. J. Hematol. 2017;92:94–108. doi: 10.1002/ajh.24607. - DOI - PubMed
    1. Volpe V.O., Garcia-Manero G., Komrokji R.S. Myelodysplastic Syndromes: A New Decade. Clin. Lymphoma Myeloma Leuk. 2022;22:1–16. doi: 10.1016/j.clml.2021.07.031. - DOI - PubMed
    1. Sada E., Abe Y., Ohba R., Tachikawa Y., Nagasawa E., Shiratsuchi M., Takayanagi R. Vitamin K2 modulates differentiation and apoptosis of both myeloid and erythroid lineages. Eur. J. Haematol. 2010;85:538–548. doi: 10.1111/j.1600-0609.2010.01530.x. - DOI - PubMed